脓毒性休克液体复苏策略的共识与争议

2022-06-20 天津医科大学第二医院重症医学科 医学综述

脓毒性休克是脓毒症的一个亚型,也是重症监护病房患者死亡的主要原因。临床早期识别和干预脓毒症对于改善患者预后至关重要。脓毒性休克的病理生理机制较复杂,涉及外周血管张力下降、低血容量以及心肌抑制等。早期充

中文标题:

脓毒性休克液体复苏策略的共识与争议

发布日期:

2022-06-20

简要介绍:

脓毒性休克是脓毒症的一个亚型,也是重症监护病房患者死亡的主要原因。临床早期识别和干预脓毒症对于改善患者预后至关重要。脓毒性休克的病理生理机制较复杂,涉及外周血管张力下降、低血容量以及心肌抑制等。早期充分的晶体液复苏对于恢复循环容量至关重要,同时还应根据患者血流动力学状态、容量反应性、出入量情况、生化指标等进行阶段性液体复苏,并遵循“抢救、优化、稳定、消退”的液体复苏方案。目前关于复苏终点尚无统一标准,动态评估患者血流动力学变化有助于复苏终点的判断。 

相关资料下载:
[AttachmentFileName(sort=1, fileName=脓毒性休克液体复苏策略的共识与争议.pdf)] GetToolGuiderByIdResponse(projectId=1, id=dd8a81c002ae49b5, title=脓毒性休克液体复苏策略的共识与争议, enTitle=, guiderFrom=医学综述, authorId=0, author=, summary=脓毒性休克是脓毒症的一个亚型,也是重症监护病房患者死亡的主要原因。临床早期识别和干预脓毒症对于改善患者预后至关重要。脓毒性休克的病理生理机制较复杂,涉及外周血管张力下降、低血容量以及心肌抑制等。早期充, cover=https://img.medsci.cn/20220622/1655905077546_1608702.jpg, journalId=0, articlesId=null, associationId=2857, associationName=天津医科大学第二医院重症医学科, associationIntro=天津医科大学第二医院重症医学科, copyright=0, guiderPublishedTime=Mon Jun 20 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #666666;">脓毒性休克是脓毒症的一个亚型,也是重症监护病房患者死亡的主要原因。临床早期识别和干预脓毒症对于改善患者预后至关重要。脓毒性休克的病理生理机制较复杂,涉及外周血管张力下降、低血容量以及心肌抑制等。早期充分的晶体液复苏对于恢复循环容量至关重要,同时还应根据患者血流动力学状态、容量反应性、出入量情况、生化指标等进行阶段性液体复苏,并遵循&ldquo;抢救、优化、稳定、消退&rdquo;的液体复苏方案。目前关于复苏终点尚无统一标准,动态评估患者血流动力学变化有助于复苏终点的判断。&nbsp;</span></p>, tagList=[TagDto(tagId=23032, tagName=脓毒性休克)], categoryList=[CategoryDto(categoryId=38, categoryName=急重症, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=解读, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=11793, appHits=428, showAppHits=0, pcHits=705, showPcHits=11364, likes=2, shares=54, comments=2, approvalStatus=1, publishedTime=Thu Jun 23 11:35:00 CST 2022, publishedTimeString=2022-06-20, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=dajiong, createdTime=Wed Jun 22 21:37:43 CST 2022, updatedBy=6459136, updatedName=艺玮, updatedTime=Sat Jan 06 19:45:35 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=脓毒性休克液体复苏策略的共识与争议.pdf)])
脓毒性休克液体复苏策略的共识与争议.pdf
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2119189, encodeId=20a7211918925, content=非常有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33eb8522162, createdName=ms3000001195125005, createdTime=Mon Mar 13 11:58:51 CST 2023, time=2023-03-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1241652, encodeId=e63c124165279, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fbb2629284, createdName=578333069, createdTime=Sun Aug 28 16:47:03 CST 2022, time=2022-08-28, status=1, ipAttribution=)]
    2023-03-13 ms3000001195125005 来自江苏省

    非常有用

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2119189, encodeId=20a7211918925, content=非常有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33eb8522162, createdName=ms3000001195125005, createdTime=Mon Mar 13 11:58:51 CST 2023, time=2023-03-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1241652, encodeId=e63c124165279, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fbb2629284, createdName=578333069, createdTime=Sun Aug 28 16:47:03 CST 2022, time=2022-08-28, status=1, ipAttribution=)]
    2022-08-28 578333069

    非常好

    0